Quetiapine 300 mg Tablet PCD Franchise in Ahmedabad

Anti-Psychotic Medicine Supplier in Chennai

Bipolar Disorder Treatment Tablet Distributor in Mumbai

CNS & Psychiatry Pharma Franchise in Jaipur

Quetiapine 300 mg Tablet Stockist in Lucknow
Psychiatric Medicine Export and Manufacturing in Hyderabad

Home/Products /quetiapine-300-mg-tablet

About the Product

Description


Qtpair 300 Tablet contains Quetiapine 300mg, an atypical antipsychotic medication used for managing schizophrenia, bipolar disorder, and depression associated with bipolar disorder. It works by balancing serotonin and dopamine levels in the brain, helping stabilize mood, reduce agitation, and improve cognitive and behavioral symptoms.

This formulation belongs to the CNS and psychiatry therapeutic segment and is widely prescribed in moderate to severe psychiatric cases or when lower strengths do not provide sufficient therapeutic response. Due to its long-term treatment role, the product ensures strong prescription continuity and repeat demand.

Qtpair 300 Tablet is commonly used in hospitals, psychiatric centers, neurology clinics, and rehabilitation care. It supports long-term mental health stability, making it a key product in psychiatric treatment protocols.

For PCD pharma distributors, exporters, and third-party manufacturing clients, Qtpair 300 offers a profitable and high-demand business opportunity within the neurology and mental health market. It is suitable for franchise expansion, bulk purchase, institutional supply, and private label orders across India.

Common side effects may include: Drowsiness, dizziness, weight gain, dry mouth, constipation, increased appetite, and fatigue. Rare but serious side effects include metabolic changes, low white blood cell count, heart rhythm irregularities, and severe allergic reactions.

It is commonly used for the treatment of: Schizophrenia Bipolar disorder (mania and bipolar depression) Major depressive disorder (as add-on therapy) It helps reduce symptoms like hallucinations, delusions, irritability, mood swings, and emotional instability.

Take exactly as directed by the physician. Do not stop the medication suddenly, as it may worsen symptoms. Avoid alcohol and alertness-requiring activities. Regular monitoring of weight, blood pressure, and blood sugar may be required.

Store below 25°C in a dry, cool place away from heat and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Quetiapine 300mg Tablet in the PCD pharma franchise market?

Quetiapine 300mg Tablet has strong demand in the psychiatry, mental healthcare, and CNS (Central Nervous System) care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neuropsychiatric medicine portfolios.

Why should medical distributors include Quetiapine 300mg Tablet in their product range?

Medical distributors and agencies can benefit from demand for psychiatric disorder management under specialist supervision. Quetiapine 300mg is an atypical antipsychotic medication used in mental healthcare Commonly prescribed for the management of schizophrenia, bipolar disorder, and other psychiatric conditions as advised by healthcare professionals Helps manage symptoms such as hallucinations, delusions, mood disturbances, agitation, and behavioral changes in appropriate patients Higher-strength formulation supports individualized treatment plans and maintenance therapy as determined by healthcare professionals Oral tablet formulation provides convenient administration for long-term treatment under medical supervision Requires regular monitoring and dosage adjustments based on patient response and clinical requirements Frequently utilized in psychiatry clinics, mental healthcare centers, hospitals, and specialty CNS care facilities Widely prescribed by psychiatrists and mental health specialists This strengthens a comprehensive psychiatry and CNS care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Quetiapine 300mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from specialty healthcare market opportunities, consistent prescription demand, repeat purchases, reliable supply chain support, and attractive margins in the neuropsychiatric segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.